Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Investigative Ophthalmology & Visual Science|March 16, 2022
The RUSH2A Study: Dark-Adapted Visual Fields in Patients With Retinal Degeneration Associated With Biallelic Variants in the USH2A GeneDavid G Birch, Lassana Samarakoon, Michele Melia, et al.
Investigative Ophthalmology & Visual Science|August 12, 2025
Progression of Dark-Adapted Visual Fields Over 3 Years in the Rate of Progression in USH2A-Related Retinal Degeneration (RUSH2A) StudyDavid G Birch, Jacque L Duncan, Lassana Samarakoon, et al.
Cornea|March 28, 2025
Central Cornea Changes on Anterior Segment OCT and In Vivo Confocal Microscopy After Autologous Limbal Epithelial Cell TransplantationLeyla Yavuz Saricay, Aaron R Kaufman, Lynette K Johns, et al.
American Journal of Ophthalmology|December 22, 2023
Functional Vision in Patients With Biallelic USH2A VariantsElise Heon, Michele Melia, Laura E Bocchino, et al.
Nature Communications|March 4, 2025
Cultivated autologous limbal epithelial cell (CALEC) transplantation for limbal tem cell deficiency: a phase I/II clinical trial of the first xenobiotic-free, serum-free, antibiotic-free manufacturing protocol developed in the USUla V Jurkunas, Aaron R Kaufman, Jia Yin, et al.
Science Advances|August 18, 2023
Cultivated autologous limbal epithelial cell (CALEC) transplantation: Development of manufacturing process and clinical evaluation of feasibility and safetyUla V Jurkunas, Jia Yin, Lynette K Johns, et al.
Investigative Ophthalmology & Visual Science|June 4, 2024
Self-Reported Functional Vision in USH2A-Associated Retinal Degeneration as Measured by the Michigan Retinal Degeneration QuestionnaireBela Parekh, Jacque L Duncan, Lassana Samarakoon, et al.
Investigative Ophthalmology & Visual Science|February 5, 2025
Characterizing the Genetic Basis for Inherited Retinal Disease: Lessons Learned From the Foundation Fighting Blindness Clinical Consortium's Gene PollKari Branham, Lassana Samarakoon, Isabelle Audo, et al.
Translational Vision Science & Technology|October 9, 2024
Endpoints and Design for Clinical Trials in USH2A-Related Retinal Degeneration: Results and Recommendations From the RUSH2A Natural History StudyMaureen G Maguire, David G Birch, Jacque L Duncan, et al.
Pageof 1